ZSCAN20: A Protein Potential Drug Target and Biomarker (G7579)

Target Name: ZSCAN20

NCBI ID: G7579

ZSCAN20

ZSCAN20: A Protein Potential Drug Target and Biomarker

ZSCAN20, also known as Zinc finger and SCAN domain containing 20, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the Zinc finger gene family, which is known for the ability of these proteins to interact with DNA and regulate gene expression. ZSCAN20 is characterized by the presence of a zinc finger domain and a SCAN domain, which is a structural domain that is similar to the protein-coding regions of certain RNA viruses.

The zinc finger gene family is a large family of non-coding RNAs that are characterized by the presence of a zinc finger domain. This domain is a conserved structural motif that is found in many proteins, including ZSCAN20. The zinc finger domain is responsible for the ability of these proteins to interact with DNA and regulate gene expression.

The SCAN domain is a structural motif that is found in some proteins, including ZSCAN20. It is a regions of the protein that contains a specific sequence that is involved in the formation of a stem-loop structure. This motif is responsible for the ability of these proteins to interact with other proteins and molecules, including DNA and RNA.

ZSCAN20 is a protein that is expressed in various tissues and cells throughout the body. It is highly expressed in the brain, where it is involved in the development and progression of many diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative disorders. It is also expressed in other tissues, including the heart, lungs, and kidneys.

One of the reasons for the interest in ZSCAN20 is its potential as a drug target. The zinc finger domain and the SCAN domain suggest that ZSCAN20 may be involved in the regulation of gene expression and the development of many diseases. This is an area of 鈥嬧?媜ngoing research, and many researchers are interested in the potential therapeutic uses of ZSCAN20.

In addition to its potential as a drug target, ZSCAN20 is also of interest as a biomarker. The high expression of ZSCAN20 in various tissues and cells suggests that it may be a useful biomarker for the diagnosis and treatment of many diseases. For example, ZSCAN20 may be used as a biomarker for the diagnosis of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It may also be used as a biomarker for the diagnosis of other diseases, such as cancer.

In conclusion, ZSCAN20 is a protein that is characterized by the presence of a zinc finger domain and a SCAN domain. It is expressed in various tissues and cells throughout the body and is of interest as a potential drug target and biomarker. Further research is needed to fully understand the role of ZSCAN20 in the regulation of gene expression and the development of diseases.

Protein Name: Zinc Finger And SCAN Domain Containing 20

Functions: May be involved in transcriptional regulation

The "ZSCAN20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets